UBS Group AG - Net Worth and Insider Trading
UBS Group AG Net Worth
The estimated net worth of UBS Group AG is at least $827 Million dollars as of 2024-09-28. UBS Group AG is the of SciClone Pharmaceuticals (Holdings) Ltd and owns about 44,170,883 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) stock worth over $827 Million. Details can be seen in UBS Group AG's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that UBS Group AG has not made any transactions after 2024-05-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of UBS Group AG
UBS Group AG Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, UBS Group AG owns 1 companies in total, including SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) .
Click here to see the complete history of UBS Group AG’s form 4 insider trades.
Insider Ownership Summary of UBS Group AG
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:06600 | SciClone Pharmaceuticals (Holdings) Ltd | 2024-05-31 | 2201 Interest of corporation controlled by you |
UBS Group AG Latest Holdings Summary
UBS Group AG currently owns a total of 1 stock. UBS Group AG owns 44,170,883 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) as of May 28, 2024, with a value of $827 Million.
Latest Holdings of UBS Group AG
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:06600 | SciClone Pharmaceuticals (Holdings) Ltd | 2024-05-28 | 44,170,883 | 18.72 | 826,878,930 |
Holding Weightings of UBS Group AG
UBS Group AG Form 4 Trading Tracker
According to the SEC Form 4 filings, UBS Group AG has made a total of 24 transactions in SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in SciClone Pharmaceuticals (Holdings) Ltd is the sale of 0 shares on May 28, 2024, which brought UBS Group AG around $0.
Insider Trading History of UBS Group AG
- 1
UBS Group AG Trading Performance
GuruFocus tracks the stock performance after each of UBS Group AG's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by UBS Group AG is %. GuruFocus also compares UBS Group AG's trading performance to market benchmark return within the same time period. The performance of stocks bought by UBS Group AG within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how UBS Group AG's insider trading performs compared to the benchmark.
Performance of UBS Group AG
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.78 |  | | | | |
| Relative Return to S&P 500(%) | -2.11 | | | | | |
UBS Group AG Ownership Network
UBS Group AG Owned Company Details
What does SciClone Pharmaceuticals (Holdings) Ltd do?
Who are the key executives at SciClone Pharmaceuticals (Holdings) Ltd?
UBS Group AG is the 2201 Interest of corporation controlled by you of SciClone Pharmaceuticals (Holdings) Ltd. Other key executives at SciClone Pharmaceuticals (Holdings) Ltd include 2101 Beneficial owner Zhao Hong , Gl Capital Management Gp Limited , and 2201 Interest of corporation controlled by you Meng Liang .
SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) Insider Trades Summary
Over the past 18 months, UBS Group AG made 24 insider transaction in SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) with a net purchase of 354,500. Other recent insider transactions involving SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) include a net sale of 0 shares made by Zhao Hong , a net sale of 0 shares made by Ascendent Capital Partners II, GP, L.P. , and a net sale of 0 shares made by Ascendent Silver (cayman) Limited .
In summary, during the past 3 months, insiders sold 0 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) were sold and 354,500 shares were bought by its insiders, resulting in a net purchase of 354,500 shares.
SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600)'s detailed insider trading history can be found in Insider Trading Tracker table.
SciClone Pharmaceuticals (Holdings) Ltd Insider Transactions
UBS Group AG Mailing Address
Above is the net worth, insider trading, and ownership report for UBS Group AG. Currently GuruFocus does not have mailing address information for UBS Group AG.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
